Candidiasis Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 18
SKU : PH2665
excelpdfpowerpoint
180 pages
Report Summary
Table of Content
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
What is the Growth Rate of the Candidiasis Therapeutics Market?
Reach at a high CAGR of 5.3% during the forecast period 2024-2031
What Companies Are Included in the Candidiasis Therapeutics Market?
Major players are Pacgen Biopharmaceuticals, Viamet Pharmaceuticals Holdings, LLC, Novabiotics Limited, Astellas Pharma Incorporation and Cidara Therapeutics Inc.
Related Reports
healthcare-it

Digital Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 11
Starting from

$4350

pharmaceuticals

Drugs for Vulvovaginal Candidiasis Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 23
Starting from

$4350

pharmaceuticals

Cutaneous And Systemic Leishmaniasis Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 January 10
Starting from

$4350

pharmaceuticals

Antifungal Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 22
Starting from

$4350

pharmaceuticals

Myelofibrosis Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 May 23
Starting from

$4350

pharmaceuticals

Pompe Disease Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 11
Starting from

$4350